Chan, Antoni
Knitza, Johannes http://orcid.org/0000-0001-9695-0657
Article History
First Online: 7 August 2023
Competing interests
: J.K. declares non-financial interests, being part of the Digital Rheumatology Network steering board, and the following financial interests: he has or has had consulting relationships with ABATON, Abbvie, BMS, Böhringer Ingelheim, Chugai, Galapagos, Gilead, GSK, Lilly, Medac, Novartis, UCB, Vila Health and Werfen, and has received study support from ABATON, Abbvie, DFG, EIT Health, Novartis, Sanofi, Thermo Fisher and UCB. A.C. declares no competing interests.